Hisilicon: Application for issuing stocks to specific entities approved by the China Securities Regulatory Commission.

Announcement from Haisi Science: On January 16, 2026, the company received a reply from the China Securities Regulatory Commission approving Haisi Science Pharmaceutical Group Co., Ltd. to issue shares to specific entities. The CSRC has approved the company's registration application to issue shares to specific entities. This approval is valid for 12 months from the date of registration approval.